Literature DB >> 3312619

Extended-field isocentric irradiation for Hodgkin's disease.

P P Kumar, R R Good, E O Jones, J E Somers, B E McAnulty, G F McCaul, S S Rogers, M A Reeves, C K Sanders.   

Abstract

Extended-field therapeutic irradiation is the treatment of choice for the majority of patients diagnosed with pathologic stages I and II Hodgkin's disease, and total nodal irradiation can be effectively used to treat selected stage III Hodgkin's patients. Standard 100-cm source-to-axis distance extended-field isocentric technique and results are presented.

Entities:  

Mesh：

Year:  1987        PMID： 3312619      PMCID： PMC2625591     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  38 in total

1.  The interplay of radiocurability and tolerance in the irradiation of human cancers.

Authors:  G H Fletcher; L J Shukovsky
Journal:  J Radiol Electrol Med Nucl       Date:  1975-05

2.  Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications.

Authors:  R J Carmel; H S Kaplan
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

3.  Proceedings: Nodal recurrences following radical radiation therapy in Hodgkin's disease.

Authors:  P Rubin; H Keys; E Mayer; R Antemann
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-03

4.  Surgical staging of abdominal involvement in unselected patients with Hodgkin's disease.

Authors:  E Glatstein; H W Trueblood; L P Enright; S A Rosenberg; H S Kaplan
Journal:  Radiology       Date:  1970-11       Impact factor: 11.105

5.  The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-01       Impact factor: 7.038

6.  Bulky mediastinal Hodgkin's disease management and prognosis.

Authors:  K H Liew; D Easton; A Horwich; A Barrett; M J Peckham
Journal:  Hematol Oncol       Date:  1984 Jan-Mar       Impact factor: 5.271

7.  The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-Roussy.

Authors:  J M Cosset; M Henry-Amar; P Carde; D Clarke; J P Le Bourgeois; M Tubiana
Journal:  Hematol Oncol       Date:  1984 Jan-Mar       Impact factor: 5.271

8.  The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation.

Authors:  R T Hoppe
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-02       Impact factor: 7.038

9.  Patterns of care outcome studies. Results of the national practice in Hodgkin's disease.

Authors:  G E Hanks; J J Kinzie; R L White; D F Herring; S Kramer
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

10.  Radiotherapy of stage I and II Hodgkin's disease. A collaborative study.

Authors: 
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860
View more
  2 in total

1.  Radiation therapy alone versus radiation therapy and chemotherapy in the management of Hodgkin's disease.

Authors:  L D Glenn; P P Kumar
Journal:  J Natl Med Assoc       Date:  1990-02       Impact factor: 1.798

2.  Comparison and Evaluation of Different Treatment Plans with IFRT Field and 6 and 18 MV Energies in Hodgkin's Lymphoma Involvement Neck and Mediastinum.

Authors:  M B Tavakoli; M Maleki; A Akhavan; T Hadisinia; I Abedi; A Amouheidari
Journal:  J Biomed Phys Eng       Date:  2018-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.